You are here

P&T News

April 27

Hospitals, insurers, and businesses prod drug-makers
Product overcomes patent-infringement lawsuit

April 26

Nonprofit group issues safety score update
Approval decision expected by May 26
Treatment demonstrates superior improvement in lung function versus mono-components and placebo
Therapy improves overall survival, progression-free survival, and objective response rate in phase 3 trial

April 25

Hospitals should be alert for signs of infection, expert says
New data corroborate risk of PPIs
Study shows 100% cure rate in GT1b patients without use of ribavirin

April 22

Approach to predicting seasonal vaccine efficacy may need overhaul
Treatment presents substantial risk of illness or injury, agency says
Drug candidate shows clinical activity in phase II studies

Pages